13F Holdings
中文EN

HLF HERBALIFE LTD.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 1180262 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.4%
TTM net income YoY-44.0%
TTM EPS YoY-45.7%
Revenue 3-yr CAGR1.6%
Net income 3-yr CAGR-1.2%

Margins

Gross margin77.6%
Operating margin9.6%
Net margin3.4%
FCF margin6.4%
EBITDA margin11.9%

Returns

ROE—
ROA6.4%
ROIC (approx.)33.3%
Asset turnover1.89x

Leverage & solvency

Liabilities / assets114.0%
Debt / equity—
Current ratio1.19x
Interest coverage2.90x

Cash quality & payout

Operating cash flow / net income2.20x
Accruals ratio-7.8%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$5.04B$4.99B$5.06B$5.20B$5.80B
Cost of revenue$1.11B$1.10B$1.19B$1.17B$1.24B
Gross profit$3.92B$3.89B$3.87B$4.03B$4.56B
SG&A expense$1.66B$1.73B$1.70B$1.81B$2.01B
Operating income$481.00M$385.90M$356.40M$545.20M$734.10M
Interest expense$214.40M$218.30M$165.90M$139.30M$153.10M
Pretax income$275.10M$169.40M$203.00M$424.80M$560.80M
Income tax$47.30M-$84.90M$60.80M$103.50M$113.60M
Net income$228.30M$254.30M$142.20M$321.30M$447.20M
EBITDA$602.20M$507.30M$469.70M$660.60M$841.70M
EPS (basic)2.222.531.443.264.22
EPS (diluted)2.202.501.423.234.13
Weighted avg. shares (diluted)103.60M101.60M100.20M99.50M108.30M
Balance sheet
Cash & equivalents$353.10M$438.10M$595.50M$516.30M$610.40M
Receivables$91.90M$68.90M$81.20M$70.60M$66.90M
Inventory$511.70M$475.40M$505.20M$580.70M$575.70M
Current assets$1.14B$1.14B$1.40B$1.36B$1.43B
PP&E, net$447.70M$460.20M$506.50M$486.30M$442.10M
Goodwill$100.50M$87.70M$95.40M$93.20M$95.40M
Intangibles$315.10M$312.30M$314.00M$315.70M$317.30M
Total assets$2.79B$2.73B$2.81B$2.73B$2.82B
Current liabilities$1.01B$1.23B$1.28B$976.60M$1.08B
Short-term debt$20.90M$283.50M$309.50M$29.50M$29.40M
Long-term debt$1.97B$1.98B$2.25B$2.66B$2.73B
Total debt$1.99B$2.26B$2.56B$2.69B$2.76B
Total liabilities$3.30B$3.53B$3.87B$4.00B$4.21B
Shareholders' equity-$515.10M-$801.10M-$1.06B-$1.27B-$1.39B
Net debt$1.64B$1.82B$1.97B$2.18B$2.15B
Shares outstanding103.30M101.20M99.20M97.90M100.80M
Cash flow statement
Operating cash flow$333.30M$285.40M$357.50M$352.50M$460.30M
Capital expenditure$80.40M$122.00M$135.00M$156.40M$151.40M
Free cash flow$252.90M$163.40M$222.50M$196.10M$308.90M
Investing cash flow-$108.70M-$84.60M-$134.80M-$156.20M-$156.40M
Financing cash flow-$295.50M-$335.30M-$148.30M-$264.70M-$728.60M
Depreciation & amortization$121.20M$121.40M$113.30M$115.40M$107.60M
Stock-based compensation$44.10M$50.00M$48.00M$44.40M$54.10M
Share buybacks$8.20M$8.30M$11.00M$146.70M$1.01B

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.